231 related articles for article (PubMed ID: 36768307)
21. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
[TBL] [Abstract][Full Text] [Related]
22. CD44
Hui D; Chen J; Jiang Y; Pan Y; Zhang Z; Dong M; Shao C
Exp Cell Res; 2020 May; 390(2):111968. PubMed ID: 32197932
[TBL] [Abstract][Full Text] [Related]
23. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of the canonical NF-κB signaling pathway in EBV-associated gastric carcinoma.
Zhang Y; Liu W; Zhang W; Wang W; Song Y; Xiao H; Luo B
Virology; 2019 Jun; 532():1-10. PubMed ID: 30974373
[TBL] [Abstract][Full Text] [Related]
25. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.
Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS
Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P
Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma.
Liu X; Wang Y; Wang X; Sun Z; Li L; Tao Q; Luo B
Arch Virol; 2013 Jan; 158(1):123-32. PubMed ID: 23001722
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus miR-BART2-5p and miR-BART11-5p regulate cell proliferation, apoptosis, and migration by targeting RB and p21 in gastric carcinoma.
Zhao MH; Liu W; Zhang X; Zhang Y; Luo B
J Med Virol; 2023 Jan; 95(1):e28338. PubMed ID: 36418188
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
30. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
[TBL] [Abstract][Full Text] [Related]
31. Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer.
Jing JJ; Li H; Wang ZY; Zhou H; Sun LP; Yuan Y
Future Oncol; 2020 Feb; 16(6):187-197. PubMed ID: 31989840
[No Abstract] [Full Text] [Related]
32. Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments.
Yau TO; Tang CM; Yu J
World J Gastroenterol; 2014 Jun; 20(21):6448-56. PubMed ID: 24914366
[TBL] [Abstract][Full Text] [Related]
33. Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma.
Kuang X; Sun L; Liu S; Zhao Z; Zhao D; Liu S; Luo B
Virol Sin; 2016 Aug; 31(4):306-13. PubMed ID: 27535066
[TBL] [Abstract][Full Text] [Related]
34. Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer.
Kang BW; Baek DW; Kang H; Baek JH; Kim JG
Anticancer Res; 2019 Aug; 39(8):4003-4010. PubMed ID: 31366481
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis.
Morales-Sanchez A; Fuentes-Panana EM
Curr Cancer Drug Targets; 2017; 17(6):534-554. PubMed ID: 27677953
[TBL] [Abstract][Full Text] [Related]
37. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms.
Cheng N; Hui DY; Liu Y; Zhang NN; Jiang Y; Han J; Li HG; Ding YG; Du H; Chen JN; Shao CK
Gastric Cancer; 2015 Apr; 18(2):246-55. PubMed ID: 24771002
[TBL] [Abstract][Full Text] [Related]
38. Screening and identification of key genes in EBV-associated gastric carcinoma based on bioinformatics analysis.
Wang H; Zhou L; Yang Y; Luo B
Pathol Res Pract; 2021 Jun; 222():153439. PubMed ID: 34020134
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
[TBL] [Abstract][Full Text] [Related]
40. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M
PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
